BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 22, 2013
View Archived Issues
Novel protease inhibitors exhibit broad-spectrum antiviral activity
Read More
A potential new biomarker for predicting recurrence of HCC
Read More
Exelixis describes discovery of a novel small-molecule mTOR inhibitor
Read More
AbbVie initiates phase III renal outcomes study of atrasentan in diabetic nephropathy
Read More
RaQualia reports data from first-in-human study of RQ-00000010
Read More
Grant supports development of Metabolomic Technologies' colonic polyp screening test
Read More
Pasireotide may have potential in treatment of postoperative dumping syndrome
Read More
Mucosis presents preclinical SynGEM data
Read More
Actavis to acquire Warner Chilcott
Read More
Baxter obtains marketing approval in Europe for HyQvia
Read More
Biogen Idec submits BLA to FDA for Plegridy in multiple sclerosis
Read More
Grifols and Aradigm agree for Pulmaquin and possible partial stock adquisition
Read More
Intercell obtains approval for Ixiaro in pediatric patients in the U.S.
Read More
New orexin OX2 receptor antagonists prepared at Merck & Co.
Read More
KineMed and MedImmune to study protein dynamics in neurodegenerative diseases
Read More
Galderma presents new CXCR2 receptor antagonists
Read More
Liquidia Technologies extends collaboration with PATH
Read More
Pharmaxis meets with the FDA regarding path to approval for Bronchitol
Read More
Merck & Co. synthesizes novel ROMK blockers
Read More
Sorrento Therapeutics receives continued NIAID support
Read More
New mGlu receptor modulators divulged by Merck & Co.
Read More
Recombinant LCAT replacement therapy mobilizes excess cholesterol from tissue in vivo
Read More
UCB and IBM collaborate on personalize care for epilepsy
Read More
NicOx patents new nitric oxide donors
Read More
Chinese researchers patent new tyrosine-protein kinase inhibitors
Read More
EMA grants accelerated assessment to Gilead's MAA for sofosbuvir
Read More